Risankizumab for Induction and Maintenance of Remission in Crohn's Disease. Khanna R. Gastroenterology 2022;163:1470-1471.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Khanna R. Risankizumab for Induction and Maintenance of Remission in Crohn's Disease. Gastroenterology 2022;163:1470-1471.
PMID: 35961380